The aim of the study is to find out whether conservative treatment - expectant management or medical therapy using misoprostol is beneficial in the case of uterine residua, and which treatment is better.
Retained products of conception are estimated to occur after approximately 1-6% of pregnancies, probably more often after termination of early pregnancies then after term pregnancy. Complication are abdominal pain, infection, bleeding and for the long term - intrauterine adhesions.Blood clots in the uterine cavity can cause similar complications. The definitive treatment is curettage or hysteroscopy, both of which are carried out under general anesthesia and require an operating theater. Although expectant management and uterotonic drugs are practically used in such situation, they are not described in the literature.This study compare between the outcome of misoprostol treatment and expectant management in the case of intrauterine residua after completion of pregnancy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
23
8oo mcg intravaginal, second dose after one day if there is no response
HaEmek medical center
Afula, Israel
abscence of sonographic finding in the uterine cavity
ofter one week, the patients will undergo an US examination.Failure of management defined as uterine cavity width \> 15mm
Time frame: one week since recruitment
Complications
During the study,there will be collection of data considering pain, bleeding, infection and surgical evacuation.
Time frame: Within one week since recruitment
Woman's satisfaction
At the end of the week, the patient will be asked about her satisfaction with the treatment
Time frame: One week since recruitment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.